Suppr超能文献

腺苷A受体组成型活性突变体的晶体结构

Crystal structure of a constitutive active mutant of adenosine A receptor.

作者信息

Cui Min, Zhou Qingtong, Xu Yueming, Weng Yuan, Yao Deqiang, Zhao Suwen, Song Gaojie

机构信息

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, People's Republic of China.

Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, People's Republic of China.

出版信息

IUCrJ. 2022 Mar 17;9(Pt 3):333-341. doi: 10.1107/S2052252522001907. eCollection 2022 May 1.

Abstract

The adenosine A receptor (AAR) is a prototypical member of the class A subfamily of G-protein-coupled receptors (GPCRs) that is widely distributed in various tissues and organs of the human body, and participates in many important signal-regulation processes. We have previously summarized a common activation pathway of class A GPCRs in which a series of conserved residues/motifs undergo conformational change during extracellular agonist binding and finally induce the coupling of intracellular G protein. Through this mechanism we have successfully predicted several novel constitutive active or inactive mutations for AAR. To reveal the molecular mechanism of mutation-induced constitutive activity, we determined the structure of a typical mutant I92N complexed with the agonist UK-432097. The mutated I92N forms a hydrophilic interaction network with nearby residues including Trp of the CWxP motif, which is absent in wild-type AAR. Although the mutant structure is similar overall to the previously determined intermediate-state AAR structure (PDB ID 3qak) [Xu, Wu, Katritch, Han, Jacobson, Gao, Cherezov & Stevens (2011). , , 322-327 ▸], molecular dynamics simulations suggest that the I92N mutant stabilizes the metastable intermediate state through the hydrophilic interaction network and favors the conformational transition of the receptor towards the active state. This research provides a structural template towards the special pharmacological outcome triggered by conformational mutation and sheds light on future structural or pharmaco-logical studies among class A GPCRs.

摘要

腺苷 A 受体(AAR)是 G 蛋白偶联受体(GPCR)A 类亚家族的典型成员,广泛分布于人体的各种组织和器官中,并参与许多重要的信号调节过程。我们之前总结了 A 类 GPCR 的一种常见激活途径,即在细胞外激动剂结合过程中,一系列保守残基/基序会发生构象变化,最终诱导细胞内 G 蛋白的偶联。通过这种机制,我们成功预测了 AAR 的几个新型组成型活性或非活性突变。为了揭示突变诱导的组成型活性的分子机制,我们确定了与激动剂 UK-432097 复合的典型突变体 I92N 的结构。突变的 I92N 与附近的残基形成了一个亲水相互作用网络,包括 CWxP 基序中的色氨酸,而野生型 AAR 中不存在这种相互作用。尽管突变体结构总体上与之前确定的中间态 AAR 结构(PDB ID 3qak)[Xu, Wu, Katritch, Han, Jacobson, Gao, Cherezov & Stevens (2011). , , 322 - 327 ▸]相似,但分子动力学模拟表明,I92N 突变体通过亲水相互作用网络稳定了亚稳态中间态,并有利于受体向活性状态的构象转变。这项研究为构象突变引发的特殊药理结果提供了一个结构模板,并为未来 A 类 GPCR 的结构或药理学研究提供了线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e423/9067115/706a03119d0d/m-09-00333-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验